Last CNY7.70 CNY
Change Today +0.01 / 0.13%
Volume 9.9M
600222 On Other Exchanges
Symbol
Exchange
Shanghai
As of 2:05 AM 11/27/14 All times are local (Market data is delayed by at least 15 minutes).

henan taloph pharmaceutica-a (600222) Snapshot

Open
CNY7.71
Previous Close
CNY7.69
Day High
CNY7.72
Day Low
CNY7.66
52 Week High
10/16/14 - CNY8.97
52 Week Low
01/10/14 - CNY5.80
Market Cap
3.8B
Average Volume 10 Days
6.8M
EPS TTM
CNY0.05
Shares Outstanding
496.6M
EX-Date
06/13/14
P/E TM
140.8x
Dividend
CNY0.03
Dividend Yield
0.32%
Current Stock Chart for HENAN TALOPH PHARMACEUTICA-A (600222)

Related News

No related news articles were found.

henan taloph pharmaceutica-a (600222) Related Businessweek News

No Related Businessweek News Found

henan taloph pharmaceutica-a (600222) Details

Henan Taloph Pharmaceutical Stock Co., Ltd. develops, manufactures, and sells traditional Chinese medicines and western pharmaceuticals in China. The company offers oral solutions, transfusion products, and tablets. Its products include Chinese medicinal oral solutions, such as Shuanghuanglian oral solutions for curing cold; solid preparations, including Glipizide tablets for curing diabetes and Huperzine A tablets for memory improvement; and injections comprising Fluconazole injection for curing virus infection. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. Henan Taloph Pharmaceutical Stock Co., Ltd. is based in Zhengzhou, China.

henan taloph pharmaceutica-a (600222) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

henan taloph pharmaceutica-a (600222) Key Developments

Henan Taloph Pharmaceutical Stock Co., Ltd. Announces Earnings Results for the Nine Months of 2014

Henan Taloph Pharmaceutical Stock Co., Ltd. announced earnings results for the nine months of 2014. For the nine months, the company reported operating revenue of CNY 871.857 million, narrowing 3.31% from a year earlier. Net profit attributable to shareholders reached CNY 11.2176 million, declining 44.16%. Basic EPS were CNY 0.0226. Weighted average return on net assets was 1.07%.

Henan Taloph Pharmaceutical Stock Co., Ltd., Board Meeting, Oct 23, 2014

Henan Taloph Pharmaceutical Stock Co., Ltd., Board Meeting, Oct 23, 2014. Agenda: To discuss and approve the proposal of third quarter report of 2014 and its abstract; to discuss and approve the proposal of investment in establishing Jiaozuo Tailong Food Health Co. Ltd.; and to discuss and approve the proposal of changing its accounting policy.

Henan Taloph Pharmaceutical Stock Co., Ltd. to Report Q3, 2014 Results on Oct 25, 2014

Henan Taloph Pharmaceutical Stock Co., Ltd. announced that they will report Q3, 2014 results on Oct 25, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600222:CH CNY7.70 CNY +0.01

600222 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600222.
View Industry Companies
 

Industry Analysis

600222

Industry Average

Valuation 600222 Industry Range
Price/Earnings 100.0x
Price/Sales 3.0x
Price/Book 3.6x
Price/Cash Flow 140.5x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HENAN TALOPH PHARMACEUTICA-A, please visit www.taloph.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.